The effects of magnesium, l-carnitine, and concurrent magnesiuml-carnitine supplementation in migraine prophylaxis
[DOI] [PubMed] [Google Scholar] 8.Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC
Although interest in using GLP-1RAs for obesity treatment is notably growing, it is tempting to directly associate the cardiovascular improvements seen with GLP-1RA therapy to weight reduction as the extent of weight loss induced by GLP-1RAs does not completely explain the observed cardiovascular benefits [69]
Third, although we applied IPTW to balance the baseline characteristics between the two groups, the potential residual confounding effect due to unobserved variables may still exist
No other approved or investigational obesity therapy has matched the 24% figure at any dose in a published trial of comparable design